Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/10/2011 | US20110277065 Plants and seeds of corn variety cv599033 |
11/10/2011 | US20110277064 Plants and seeds of corn variety cv397769 |
11/10/2011 | US20110277062 Soybean variety xb28b10 |
11/10/2011 | US20110277061 Soybean variety xb27l10 |
11/10/2011 | US20110277060 Soybean variety xb21d10 |
11/10/2011 | US20110277059 Soybean variety xb16p10 |
11/10/2011 | US20110277058 Soybean variety xb31g10 |
11/10/2011 | US20110277057 Soybean variety xb007f10 |
11/10/2011 | US20110277056 Soybean variety xb005c10 |
11/10/2011 | US20110277055 Soybean variety xb14y10 |
11/10/2011 | US20110277054 Soybean variety xb09f10 |
11/10/2011 | US20110277053 Soybean variety xb02u10 |
11/10/2011 | US20110277052 Soybean Variety XR29T10 |
11/10/2011 | US20110277050 System and methods to control transgene expression |
11/10/2011 | US20110277049 Production of cloned offspring from cooled carcasses |
11/10/2011 | US20110277048 Transgenic Aves Producing Human Polyclonal Antibodies |
11/10/2011 | US20110277047 Genetically Modified Non-Human Mammals and Cells |
11/10/2011 | US20110277046 Hydrolases, nucleic acids encoding them and methods for making and using them |
11/10/2011 | US20110277044 Polypeptides having esterase activity and nucleic acids encoding the same |
11/10/2011 | US20110277043 Desaturases and Process for the Production of Polyunsaturated Fatty Acids in Transgenic Organisms |
11/10/2011 | US20110275785 HIGHLY BRANCHED HK PEPTIDES AS EFFECTIVE CARRIERS OF siRNA |
11/10/2011 | US20110275697 Regulation of cyclin d |
11/10/2011 | US20110275674 Small Molecules Modulator of Epigenetic Regulation and Their Therapeutic Applications |
11/10/2011 | US20110275569 Proteases targeting agents |
11/10/2011 | US20110275541 Use of multiple recombination sites with unique specificity in combinational cloning |
11/10/2011 | US20110275526 Glycosyl transferase from chinese hamster and related methods |
11/10/2011 | US20110275158 Method of Modifying Target Region in Host DNA and Selectable Marker Cassette |
11/10/2011 | US20110275157 COMPOSITION FOR REPROGRAMMING SOMATIC CELLS TO GENERATE INDUCED PLURIPOTENT STEM CELLS, COMPRISING Bmi1 AND LOW MOLECULAR WEIGHT SUBSTANCE, AND METHOD FOR GENERATING INDUCED PLURIPOTENT STEM CELLS USING THE SAME |
11/10/2011 | US20110275156 Delivery of DNA or RNA Via Gap Junctions from Host Cells to Target Cells and a Cell-Based Delivery System for Antisense or siRNA |
11/10/2011 | US20110275150 Compstatin analogs with improved activity |
11/10/2011 | US20110275146 Fusion proteins comprising dp-178 and other viral fusion inhibitor peptides useful for treating aids |
11/10/2011 | US20110275138 Ketose 3-epimerase, its preparation and uses |
11/10/2011 | US20110275136 Amylase variants |
11/10/2011 | US20110275130 Fermentative glycerol-free ethanol production |
11/10/2011 | US20110275122 Thrombopoietic compounds |
11/10/2011 | US20110275116 Methods for control of flux in metabolic pathways through enzyme relocation |
11/10/2011 | US20110275107 Long wavelength engineered fluorescent proteins |
11/10/2011 | US20110275105 Methods of inducing pluripotency |
11/10/2011 | US20110275103 Emission ratiometric reporters of membrane pdk1 activation |
11/10/2011 | US20110275093 Novel use of adenoviruses and nucleic acids that code for said viruses |
11/10/2011 | US20110275071 Methods and Reagents for Combined PCR Amplification |
11/10/2011 | US20110275070 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
11/10/2011 | US20110274749 Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers |
11/10/2011 | US20110274718 System for Modulating Expression of Hypothalmic Brain-Derived Neurotrophic Factor (BDNF) |
11/10/2011 | US20110274711 Hla-g polypeptides and pharmaceutical uses thereof |
11/10/2011 | US20110274709 T-Cell Immunogens Derived from Anti-Viral Proteins and Methods of Using Same |
11/10/2011 | US20110274708 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling |
11/10/2011 | US20110274707 Composition for improving inflammatory disease using abh antigens |
11/10/2011 | US20110274706 Nucleic acid delivery vehicle and uses thereof |
11/10/2011 | US20110274702 Neutralizing anti-influenza a virus antibodies and uses thereof |
11/10/2011 | US20110274696 Antibodies to ccr2 |
11/10/2011 | US20110274694 ERK1/2 Posphorylation Site Specific Antibody |
11/10/2011 | US20110274691 Ferroportin antibodies and methods of use |
11/10/2011 | US20110274685 Antibodies that bind human cd27 and uses thereof |
11/10/2011 | US20110274670 Mesenchymal stem cells which express human hepatic growth factor,manufacturing method thereof, and use thereof as therapeutic agent for liver diseases |
11/10/2011 | US20110274669 Therapeutic retroviral vectors for gene therapy |
11/10/2011 | US20110274623 Stabilized Fibronectin Domain Compositions, Methods and Uses |
11/10/2011 | DE102010019336A1 Mittel zur Behandlung der Alzheimerschen Demenz Agents for the treatment of Alzheimer's dementia |
11/10/2011 | CA2805267A1 Detection and treatment of fibrosis |
11/10/2011 | CA2798764A1 Genetic signatures in hiv-1 subtype c envelope glycoproteins |
11/10/2011 | CA2797842A1 Immunogenic compositions and methods for treating neoplasia |
11/10/2011 | CA2796661A1 Modified pyr/pyl receptors activated by orthogonal ligands |
11/09/2011 | EP2385144A1 Amplification and detection reagents for HIV-1 |
11/09/2011 | EP2385139A1 Polymorphisms for predicting disease and treatment outcome |
11/09/2011 | EP2385138A1 Polymorphisms for predicting disease and treatment outcome |
11/09/2011 | EP2385137A1 Polymorphisms for predicting disease and treatment outcome |
11/09/2011 | EP2385133A2 Yeast cell surface display of proteins and uses thereof |
11/09/2011 | EP2385130A1 Method for producing recombinant proteins from plant hairy roots |
11/09/2011 | EP2385129A1 Enhanced methods for gene regulation in plants |
11/09/2011 | EP2385128A1 Modulation of germination, elongation growth and flowering time in plants |
11/09/2011 | EP2385127A1 Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870 |
11/09/2011 | EP2385126A1 Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870 |
11/09/2011 | EP2385125A2 Method of producing biologically active vitamin K dependent proteins by recombinant methods |
11/09/2011 | EP2385123A1 MicroRNA molecules |
11/09/2011 | EP2385122A1 MicroRNA molecules |
11/09/2011 | EP2385121A1 Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents |
11/09/2011 | EP2385120A1 Use of anti-miRNA antisense oligonucleotides for the treatment of pulmonary hypertension |
11/09/2011 | EP2385119A1 Respiratory syncytial virus (RSV) viral load detection assay |
11/09/2011 | EP2385118A1 In vitro peptide expression library |
11/09/2011 | EP2385117A1 HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
11/09/2011 | EP2385116A1 Nucleic acid derived from hepatitis c virus, and expression vector, transformed cell and hepatitis c virus particles each prepared by using same |
11/09/2011 | EP2385115A1 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof |
11/09/2011 | EP2385114A1 Diagnosis of treatment of cancer using anti-tm4sf20 antibody |
11/09/2011 | EP2385109A2 A group of esterases for the enantioselective production of fine and speciality chemicals |
11/09/2011 | EP2385108A1 Aldolases, nucleic acids encoding them and methods for making and using them |
11/09/2011 | EP2385107A1 Lentiviral vector based immunological compounds against malaria |
11/09/2011 | EP2385104A1 Variant Scytalidium thermophilium CBH1 |
11/09/2011 | EP2385103A2 Variant Hypocrea jecorina CBH1 |
11/09/2011 | EP2385069A2 Neonatal Fc rReceptor (FcRn)- binding polypeptide variants, dimeric Fc binding proteins and methods related thereto |
11/09/2011 | EP2385068A1 Polyclonal antiserum for use in immunotherapy |
11/09/2011 | EP2385067A1 Artificial antibody polypeptides |
11/09/2011 | EP2385064A2 Agents disrupting a growth factor complex |
11/09/2011 | EP2385063A2 Growth factor complex |
11/09/2011 | EP2385058A1 Method for detecting the expression of a human endogenous retrovirus envelope protein and uses of a coding gene for said protein |
11/09/2011 | EP2385056A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
11/09/2011 | EP2384766A1 Novel antibody to a carbonic anhydrase |
11/09/2011 | EP2384764A2 Compositions and methods for modulating hemostasis using variant forms of activated factor V |
11/09/2011 | EP2384369A2 Adult stem cell assays |
11/09/2011 | EP2384366A2 Transgenically preventing establishment and spread of transgenic algae in natural ecosystems |
11/09/2011 | EP2384336A1 A variant of mite allergen and uses thereof |